GLYCANOSTICS WINS NATIONAL ROUND OF CENTRAL EUROPEAN STARTUP AWARDS
With the unique, glycan-based technology and possible benefits forpatients, clinicians and society, Glycanostics was announced as a CESA awardwinner in two independent categories – Best Health-Tech Startup and Best SocialImpact Startup. As a winner in the latter category, Glycanostics became a partof this year´s Accace life accelerator (by Accace company), which ended up withan investor […]
GLYCANOSTICS WINS HORIZON 2020 GRANT
After receiving the prestigious “Seal of Excellence” from the European Commission on October 23, 2018, Glycanostics‘ next submission, to the Horizon 2020 Programme, won a € 50 000 grant. The Horizon 2020 Programme for Research and Innovation 2014-2020 aims to support excellent science, industrial leadership and social impact startups. Its main goal is to ensure that European countries […]
GLYCANOSTICS RECEIVES THE PRESTIGIOUS HORIZON 2020 “SEAL OF EXCELLENCE”
The European Commission awarded Glycanostics the prestigious Seal of Excellence for its revolutionary prostate cancer early diagnostic tests. This project was submitted under the Horizon 2020 Programme for Research and Innovation 2014-2020, and received the highest scores for its proposal in the extremely competitive evaluation process. The European Commission has a rigorous evaluation system—with a panel of […]
GLYCANOSTICS WINS TOP-6 BEST STARTUPS IN CENTRAL EUROPE
The FutureNow startup competition, also known as the Startup Awards, is akin to the Oscars for the best startups with global potential. This year marked the eighth and largest occurrence of the competition, open to participants from 17 European countries, with 128 registered start-ups. Glycanostics was chosen as a finalist in the Grand Finale with […]
GLYCANOSTICS SUCCESFULLY FINISHED HORIZON 2020 SME INSTRUMENT 1 GRANT
In august 2019, Glycanostics successfully finished the first phase of SME Instrument, by finishing a feasibility study and a business plan with the help from advisors and a consultation agency. Further information are in the Publishable summary, which can be downloaded from this link.
GLYCANOSTICS WINS THE EUROPEAN RESEARCH COUNCIL GRANT
Glycanostics innovations are again supported and highly ranked by leading industry experts. This time the company won the European Research Council (ERC) Proof of Concept Grant. The ERC president Jean Pierre Bourguignon mentioned that their Pannel recommended Glycanostics proposal for funding at the sufficiently high position in the rank list. He is confident that the grant […]
GLYCANOSTICS ZÍSKALA 3. MIESTO V SÚŤAŽI „IDEA OF THE YEAR“ SPOLOČNOSTI VODAFONE
S radosťou oznamujeme, že spoločnosť Glycanostics obsadila tretie miesto v súťaži Vodafone Idea of the Year 2018, prestížnej udalosti pre začínajúce startupy. Cieľom súťaže je aktívne podporovať inovatívne projekty s vysokým trhovým potenciálom prostredníctvom poskytovania mentoringu, sprostredkovania investícií v hodnote až 10 miliónov českých korún, internacionalizácie projektov a nadväzovania prospešných kontaktov. Je to najstaršia súťaž […]
JAN TKAC AND TOMAS BERTOK – VÍŤAZI CENY „VEDCI ROKA“ – ZALOŽILI SPOLOČNOSŤ GLYCANOSTICS, ABY UVIEDLI SVOJU REVOLÚCNU INOVÁCIU NA TRH S DIAGNOSTICKÝMI PRÍSTROJMI PRE RAKOVINU
Glycanostics je inovatívny start-up, ktorý bol založený v roku 2017 s cieľom uviesť svoje revolučné produkty v oblasti diagnostiky rakoviny na trhy v USA a EÚ. Spoločnosť založili dvaja výnimoční vedci, doc. Jan Tkáč a doc. Tomáš Bertoš, ktorí získali medzinárodné uznanie za svoje vedecké práce, prestížne granty a ocenenia, ako napríklad titul Vedec roka […]
